Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SOFTMAX CoTSE:3671 +2.95%79 EV-to-EBITDA is 18.04 as of Aug. 26, 2026, which is 110% above its 10-year median of 8.60. GuruFocus rates TSE:3671 with a GF Score™ of 79/100 and a GF Value™ of 円285.69 (Fairly Valued). The stock has 6 warning signs investors should review. Among 517 Healthcare Providers & Services companies, SOFTMAX Co ranks worse than 73.11% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SOFTMAX Co's enterprise value is 円7,221 Mil.
SOFTMAX Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was 円400 Mil. Therefore, SOFTMAX Co's EV-to-EBITDA for today is 18.04.
The historical rank and industry rank for SOFTMAX Co's EV-to-EBITDA or its related term are showing as below:
TSE:3671'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.91 Med: 8.6 Max: 91.6
Current: 18.04
During the past 13 years, the highest EV-to-EBITDA of SOFTMAX Co was 91.60. The lowest was -27.91. And the median was 8.60.
TSE:3671's EV-to-EBITDA is ranked worse than 73.11% of 517
companies
in the Healthcare Providers & Services industry
Industry Median: 10.63
vs TSE:3671: 18.04
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SOFTMAX Co's share price for today is 円314.00.
SOFTMAX Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円10.390.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for SOFTMAX Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3671 vs VEEV, BTSG, HQY: EV-to-EBITDA Comparison
For the Health Information Services subindustry, SOFTMAX Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOFTMAX Co EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SOFTMAX Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where SOFTMAX Co's EV-to-EBITDA falls into.
SOFTMAX Co's current Enterprise Value is 円7,221 Mil.
SOFTMAX Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円400 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOFTMAX Co (TSE:3671) has a EV-to-EBITDA of 18.04 as of Aug. 26, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SOFTMAX Co. This is 110% above median its historical median of 8.60. According to the industry distribution chart, SOFTMAX Co ranks #378 out of 517 companies in the Healthcare Providers & Services industry, placing it in the top 73.1%.
Is SOFTMAX Co's EV-to-EBITDA too high?
SOFTMAX Co's current EV-to-EBITDA of 18.04 is 110% above median its 10-year median of 8.60. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.63. SOFTMAX Co's value of 18.04 is 69.7% above this industry median. Based on the distribution chart, SOFTMAX Co ranks #378 out of 517 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, SOFTMAX Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does SOFTMAX Co's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SOFTMAX Co ranks #378 out of 517 companies for EV-to-EBITDA. This places SOFTMAX Co in the lower half of its industry. The industry median EV-to-EBITDA is 10.63. SOFTMAX Co's value of 18.04 is 69.7% above this benchmark. While the company's 10-year median is 8.60 vs. the industry median of 10.63, SOFTMAX Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.63, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SOFTMAX Co's current EV-to-EBITDA of 18.04 is 69.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SOFTMAX Co. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOFTMAX Co's current EV-to-EBITDA is 18.04, which is 110% above median its own 10-year median of 8.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOFTMAX Co stock overvalued right now?
Based on GuruFocus' analysis, SOFTMAX Co (TSE:3671) is currently considered Fairly Valued. The stock's GF Value™ is 円285.69, compared to a current price of 円314.00 — trading 9.9% above its estimated fair value. The current EV-to-EBITDA is 18.04, which is 110% above median its 10-year median of 8.60 and 69.7% above the Healthcare Providers & Services industry median of 10.63. SOFTMAX Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For SOFTMAX Co (TSE:3671), the current EV-to-EBITDA is 18.04 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOFTMAX Co (TSE:3671) Overvalued in 2026?
Based on GuruFocus' analysis, SOFTMAX Co stock appears to be overvalued.
The current stock price of 円314.00 is trading 9.9% above its estimated GF Value™ of 円285.69.
GuruFocus considers SOFTMAX Co to be Fairly Valued.
Key valuation signals for TSE:3671:
EV-to-EBITDA: 18.04 (110% above median its 10-year median of 8.60)
GF Value™: 円285.69 vs. price of 円314.00 (9.9% above fair value)
Industry Position: 69.7% above the Healthcare Providers & Services median (#378 of 517)
No single metric tells the full story. See the TSE:3671 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOFTMAX Co Ltd provides optimal solutions for customers based on their developed PlusUs series such as Web type electronic charts and medical accounting. It offers Web-type electronic medical record and ordering systems, health checkup systems, radiology department information systems, rehabilitation department systems, surgical department systems, hospital goods management systems, and nursing care management systems. Geographically it operates through the region of Japan.
79GF Score
Get the complete analysis for TSE:3671
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3671 has been successfully added to your 
